Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · IEX Real-Time Price · USD
14.27
-0.05 (-0.35%)
Jul 22, 2024, 10:11 AM EDT - Market open
Enanta Pharmaceuticals Employees
Enanta Pharmaceuticals had 145 employees as of September 30, 2023. The number of employees decreased by 15 or -9.38% compared to the previous year.
Employees
145
Change (1Y)
-15
Growth (1Y)
-9.38%
Revenue / Employee
$502,628
Profits / Employee
-$908,524
Market Cap
305.83M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Adaptimmune Therapeutics | 449 |
SOPHiA GENETICS | 430 |
MacroGenics | 339 |
Poseida Therapeutics | 330 |
Sutro Biopharma | 302 |
Pulmonx | 279 |
Atea Pharmaceuticals | 75 |
Jasper Therapeutics | 45 |
ENTA News
- 7 weeks ago - Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference - Business Wire
- 2 months ago - Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference - Business Wire
- 2 months ago - Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4:30 p.m. ET - Business Wire
- 2 months ago - Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer - Business Wire
- 3 months ago - Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024 - Business Wire
- 3 months ago - Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024 - Business Wire
- 4 months ago - Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference - Business Wire